ORIGINAL RESEARCH
Accepted on 06 Oct 2025
NeoTImmuML: A Machine Learning-Based Prediction Model for Human Tumor Neoantigen Immunogenicity
doi 10.3389/fimmu.2025.1681396
- 241 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Methods in Cancer Immunity and Immunotherapy: Volume II
Community Series in Methods in Cancer Immunity and Immunotherapy: Volume II
5,432
Total downloads
22k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 02 Oct 2025
Emerging strategies in colorectal cancer immunotherapy: enhancing efficacy and survival
doi 10.3389/fimmu.2025.1616414
- 596 views
ORIGINAL RESEARCH
Accepted on 30 Sep 2025
Pterostilbene Inhibits Non-Small Cell Lung Cancer Progression by Activating the STING Pathway and Enhancing Antitumor Immune Response
doi 10.3389/fimmu.2025.1622284
- 156 views
REVIEW
Accepted on 29 Sep 2025
Significance of Circular RNAs in Regulating Protein Ubiquitination for Malignant Tumor Progression
doi 10.3389/fimmu.2025.1610112
- 188 views
ORIGINAL RESEARCH
Published on 01 Sep 2025
Urokinase-type plasminogen activator deficiency enhances CD8+ T cell infiltration and anti-PD-1 therapy efficacy in prostate cancer
doi 10.3389/fimmu.2025.1625226
- 1,037 views
METHODS
Published on 24 Apr 2025
SAPrIm 2.0: a semi-automated protocol for mid-throughput soluble HLA immunopeptidomics
doi 10.3389/fimmu.2025.1546629
- 2,503 views
ORIGINAL RESEARCH
Published on 12 Mar 2025
Zanubrutinib plus R-CHOP improves the treatment effect of newly diagnosed diffuse large B cell lymphoma with double expression of MYC and BCL-2
doi 10.3389/fimmu.2025.1526318
- 3,031 views
REVIEW
Published on 25 Feb 2025
Research progress of T cells in cholangiocarcinoma
doi 10.3389/fimmu.2025.1453344
- 1,900 views
- 1 citation
ORIGINAL RESEARCH
Published on 24 Jan 2025
Immune checkpoint inhibitor-induced diabetes mellitus: clinical characteristics and risk factors
doi 10.3389/fimmu.2025.1499074
- 2,445 views
- 2 citations
STUDY PROTOCOL
Published on 09 Oct 2024
SHR-8068 combined with adebrelimab and bevacizumab in the treatment of refractory advanced colorectal cancer: study protocol for a single-arm, phase Ib/II study
doi 10.3389/fimmu.2024.1450533
- 2,389 views
- 1 citation
CASE REPORT
Published on 16 Aug 2024
Etoposide, cisplatin, and sintilimab combined with anlotinib in successful treatment of adrenocortical carcinoma with lung metastasis: a case report
doi 10.3389/fonc.2024.1403762
- 1,149 views
- 1 citation
ORIGINAL RESEARCH
Published on 21 Mar 2024
PD-1 inhibitor combined with chemotherapy for first-line treatment of esophageal squamous cell carcinoma patients with distant metastasis: a real-world retrospective study
doi 10.3389/fimmu.2024.1353445
- 1,935 views
- 4 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: